SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity

References

• Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994;140:1–22.
   PubMed Web of Science ®Google Scholar
• Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem. 1988;57:349–374.
   PubMed Web of Science ®Google Scholar
• Mathews CK. Deoxyribonucleotides as genetic and metabolic regulators. FASEB J. 2014;28:3832–3840.
   PubMed Web of Science ®Google Scholar
• Mathews CK. DNA precursor metabolism and genomic stability. FASEB J. 2006;20:1300–1314.
   PubMed Web of Science ®Google Scholar
• Pai C, Kearsey S. A critical balance: dNTPs and the maintenance of genome stability. Genes (Basel). 2017;8:57.
   Web of Science ®Google Scholar
• Rampazzo C, Miazzi C, Franzolin E, et al. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat Res Genet Toxicol Environ Mutagen. 2010;703:2–10.
   PubMed Web of Science ®Google Scholar
• Lane AN, Fan TWM. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015;43:2466–2485.
   PubMed Web of Science ®Google Scholar
• Hofer A, Crona M, Logan DT, et al. DNA building blocks: keeping control of manufacture. Crit Rev Biochem Mol Biol. 2012;47:50–63.
   PubMed Web of Science ®Google Scholar
• Walldén K, Nordlund P. Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5′-nucleotidase II. J Mol Biol. 2011;408:684–696.
   PubMed Web of Science ®Google Scholar
• Johansson K, Ramaswamy S, Ljungcrantz C, et al. Structural basis for substrate specificities of cellular deoxyribonucleoside kinases. Nat Struct Biol. 2001;8:616–620.
   PubMedGoogle Scholar
• Hunsucker SA, Mitchell BS, Spychala J. The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther. 2005;107:1–30.
   PubMed Web of Science ®Google Scholar
• Bianchi V, Spychala J. Mammalian 5′-nucleotidases. J Biol Chem. 2003;278:46195–46198.
   PubMed Web of Science ®Google Scholar
• Nordlund P, Reichard P. Ribonucleotide reductases. Annu Rev Biochem. 2006;75:681–706.
   PubMed Web of Science ®Google Scholar
• Håkansson P, Hofer A, Thelander L. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem. 2006;281:7834–7841.
   PubMed Web of Science ®Google Scholar
• Pontarin G, Ferraro P, Bee L, et al. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Proc Natl Acad Sci USA. 2012;109:13302–13307.
   PubMed Web of Science ®Google Scholar
• Pontarin G, Ferraro P, Rampazzo C, et al. Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase. J Biol Chem. 2011;286:11132–11140.
   PubMed Web of Science ®Google Scholar
• Pontarin G, Fijolek A, Pizzo P, et al. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci. 2008;105:17801–17806.
   PubMed Web of Science ®Google Scholar
• Choi JS, Berdis AJ. Nucleoside transporters: biological insights and therapeutic applications. Future Med Chem. 2012;4:1461–1478.
   PubMed Web of Science ®Google Scholar
• Nicander B, Reichard P. Evidence for the involvement of substrate cycles in the regulation of deoxyribonucleoside triphosphate pools in 3T6 cells. Pediatr Res. 1985;260:9216–9222.
   Google Scholar
• Bianchi V, Pontis E, Reichard P. Dynamics of the dATP pool in cultured mammalian cells. Exp Cell Res. 1992;199:120–128.
   PubMed Web of Science ®Google Scholar
• Spyrou G, Reichard P. Dynamcis of the thymidine triphosphate pool during the cell cycle of synchronized 3T3 mouse fibroblasts. Mutat Res Fundam Mol Mech Mutagen. 1988;200:37–43.
   PubMed Web of Science ®Google Scholar
• Leanza L, Ferraro P, Reichard P, et al. Metabolic interrelations within guanine deoxynucleotide pools for mitochondrial and nuclear DNA maintenance. J Biol Chem. 2008;283:16437–16445.
   PubMed Web of Science ®Google Scholar
• Rampazzo C, Ferraro P, Pontarin G, et al. Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation. J Biol Chem. 2004;279:17019–17026.
   PubMed Web of Science ®Google Scholar
• Gandhi VV, Samuels DC. A review comparing deoxyribonucleoside triphosphate (dNTP) concentrations in the mitochondrial and cytoplasmic compartments of normal and transformed cells. Nucleosides Nucleotides Nucleic Acids. 2011;30:317–339.
   PubMed Web of Science ®Google Scholar
• Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res. 1989;181:305–316.
   PubMed Web of Science ®Google Scholar
• Kumar D, Abdulovic AL, Viberg J, et al. Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools. Nucleic Acids Res. 2011;39:1360–1371.
   PubMed Web of Science ®Google Scholar
• Kumar D, Viberg J, Nilsson AK, et al. Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint. Nucleic Acids Res. 2010;38:3975–3983.
   PubMed Web of Science ®Google Scholar
• Buckland RJ, Watt DL, Chittoor B, et al. Increased and imbalanced dNTP pools symmetrically promote both leading and lagging strand replication infidelity. PLoS Genet. 2014;10:e1004846.
   PubMed Web of Science ®Google Scholar
• Watt DL, Buckland RJ, Lujan SA, et al. Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools. Nucleic Acids Res. 2015;44:1669–1680.
   PubMed Web of Science ®Google Scholar
• Chabes A, Stillman B. Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2007;104:1183–1188.
   PubMed Web of Science ®Google Scholar
• Davidson MB, Katou Y, Keszthelyi A, et al. Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype. EMBO J. 2012;31:895–907.
   PubMed Web of Science ®Google Scholar
• Gemble S, Buhagiar-Labarchède G, Onclercq-Delic R, et al. A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formation. J Cell Sci. 2016;129:3167–3177.
   PubMed Web of Science ®Google Scholar
• Sabouri N, Viberg J, Goyal DK, et al. Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage. Nucleic Acids Res. 2008;36:5660–5667.
   PubMed Web of Science ®Google Scholar
• Ke PY, Kuo YY, Hu CM, et al. Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability. Genes Dev. 2005;19:1920–1933.
   PubMed Web of Science ®Google Scholar
• Hastak K, Paul RK, Agarwal MK, et al. DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation. Proc Natl Acad Sci USA. 2008;105:6314–6319.
   PubMed Web of Science ®Google Scholar
• Anglana M, Apiou F, Bensimon A, et al. Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. Cell. 2003;114:385–394.
   PubMed Web of Science ®Google Scholar
• Poli J, Tsaponina O, Crabbé L, et al. dNTP pools determine fork progression and origin usage under replication stress. EMBO J. 2012;31:883–894.
   PubMed Web of Science ®Google Scholar
• Papadopoulou C, Guilbaud G, Schiavone D, et al. Nucleotide pool depletion induces G-quadruplex-dependent perturbation of gene expression. Cell Rep. 2015;13:2491–2503.
   PubMed Web of Science ®Google Scholar
• Jasencakova Z, Scharf AND, Ask K, et al. Replication stress interferes with histone recycling and predeposition marking of new histones. Mol Cell. 2010;37:736–743.
   PubMed Web of Science ®Google Scholar
• Mathews CK. Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer. 2015;15:528–539.
   PubMed Web of Science ®Google Scholar
• Boss GR, Seegmiller JE. Genetic defects in human purine and pyrimidine metabolism. Annu Rev Genet. 1982;16:297–328.
   PubMed Web of Science ®Google Scholar
• El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects. Biochim Biophys Acta. 2017;1863:1539–1555.
   PubMed Web of Science ®Google Scholar
• Chabosseau P, Buhagiar-Labarchède G, Onclercq-Delic R, et al. Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndrome. Nat Comms. 2011;2:368.
   PubMed Web of Science ®Google Scholar
• Kimura T, Takeda S, Sagiya Y, et al. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet. 2003;34:440–445.
   PubMed Web of Science ®Google Scholar
• Aird KM, Zhang G, Li H, et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 2013;3:1252–1265.
   PubMed Web of Science ®Google Scholar
• Aird KM, Zhang R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett. 2015;356:204–210.
   PubMed Web of Science ®Google Scholar
• Chang L, Guo R, Huang Q, et al. Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasms. Cell Rep. 2013;3:1389–1397.
   PubMed Web of Science ®Google Scholar
• Oliver FJ, Collins MKL, López-Rivas A. dNTP pools imbalance as a signal to initiate apoptosis. Experientia. 1996;52:995–1000.
   PubMedGoogle Scholar
• James SJ, Basnakian AG, Miller BJ. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 1994;54:5075–5080.
   PubMed Web of Science ®Google Scholar
• Chandra D, Bratton SB, Person MD, et al. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell. 2006;125:1333–1346.
   PubMed Web of Science ®Google Scholar
• Li N, Zhang W, Cao X. Identification of human homologue of mouse IFN-γ induced protein from human dendritic cells. Immunol Lett. 2000;74:221–224.
   PubMed Web of Science ®Google Scholar
• Rice GI, Kasher PR, Forte GMA, et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet. 2012;44:1243–1248.
   PubMed Web of Science ®Google Scholar
• Powell RD, Holland PJ, Hollis T, et al. Aicardi-goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem. 2011;286:43596–43600.
   PubMed Web of Science ®Google Scholar
• Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480:379–382.
   PubMed Web of Science ®Google Scholar
• Hansen EC, Seamon KJ, Cravens SL, et al. GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state. Proc Natl Acad Sci. 2014;111:E1843–E1851.
   Google Scholar
• Amie SM, Bambara RA, Kim B. GTP Is the primary activator of the anti-HIV restriction factor SAMHD1. J Biol Chem. 2013;288:25001–25006.
   PubMed Web of Science ®Google Scholar
• Ji X, Tang C, Zhao Q, et al. Structural basis of cellular dNTP regulation by SAMHD1. Proc Natl Acad Sci USA. 2014;111:E4305–E4314.
   PubMed Web of Science ®Google Scholar
• Beauchamp BB, Richardson CC. A unique deoxyguanosine triphosphatase is responsible for the optA1 phenotype of Escherichia coli. Proc Natl Acad Sci USA. 1988;85:2563–2567.
   PubMed Web of Science ®Google Scholar
• Vorontsov II, Minasov G, Kiryukhina O, et al. Characterization of the deoxynucleotide triphosphate triphosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus faecalis and crystal structure of the activator-substrate complex. J Biol Chem. 2011;286:33158–33166.
   PubMed Web of Science ®Google Scholar
• Oganesyan V, Adams PD, Jancarik J, et al. Structure of O67745_AQUAE, a hypothetical protein from Aquifex aeolicus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007;63:369–374.
   PubMedGoogle Scholar
• Kondo N, Kuramitsu S, Masui R. Biochemical characterization of TT1383 from Thermus thermophilus identifies a novel dNTP triphosphohydrolase activity stimulated by dATP and dTTP. J Biochem. 2004;136:221–231.
   PubMed Web of Science ®Google Scholar
• Kondo N, Nakagawa N, Ebihara A, et al. Structure of dNTP-inducible dNTP triphosphohydrolase: insight into broad specificity for dNTPs and triphosphohydrolase-type hydrolysis. Acta Crystallogr Sect D Biol Crystallogr. 2007;63:230–239.
   PubMedGoogle Scholar
• Mega R, Kondo N, Nakagawa N, et al. Two dNTP triphosphohydrolases from Pseudomonas aeruginosa possess diverse substrate specificities. FEBS J. 2009;276:3211–3221.
   PubMed Web of Science ®Google Scholar
• Zimmerman MD, Proudfoot M, Yakunin A, et al. Structural insight into the mechanism of substrate specificity and catalytic activity of an HD-domain phosphohydrolase: the 5’-deoxyribonucleotidase YfbR from Escherichia coli. J Mol Biol. 2008;378:215–226.
   PubMed Web of Science ®Google Scholar
• Qiao F, Bowie JU. The many faces of SAM. Sci Signal. 2005;2005:re7–re7.
   Google Scholar
• Brandariz-Nuñez A, Valle-Casuso J, White TE, et al. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology. 2012;9:49.
   PubMed Web of Science ®Google Scholar
• Hofmann H, Logue EC, Bloch N, et al. The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol. 2012;86:12552–12560.
   PubMed Web of Science ®Google Scholar
• Aravind L, Koonin EV. The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem Sci. 1998;23:469–472.
   PubMed Web of Science ®Google Scholar
• DeLucia M, Mehrens J, Wu Y, et al. HIV-2 and SIVmac accessory virulence factor Vpx down-regulates SAMHD1 enzyme catalysis prior to proteasome-dependent degradation. J Biol Chem. 2013;288:19116–19126.
   PubMed Web of Science ®Google Scholar
• Zhu C, Gao W, Zhao K, et al. Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. Nat Commun. 2013;4:2722.
   PubMed Web of Science ®Google Scholar
• Ji X, Wu Y, Yan J, et al. Mechanism of allosteric activation of SAMHD1 by dGTP. Nat Struct Mol Biol. 2013;20:1304–1309.
   PubMed Web of Science ®Google Scholar
• Yan J, Kaur S, DeLucia M, et al. Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection. J Biol Chem. 2013;288:10406–10417.
   PubMed Web of Science ®Google Scholar
• Miazzi C, Ferraro P, Pontarin G, et al. Allosteric regulation of the human and mouse deoxyribonucleotide triphosphohydrolase sterile α-motif/histidine-aspartate domain-containing protein 1 (SAMHD1). J Biol Chem. 2014;289:18339–18346.
   PubMed Web of Science ®Google Scholar
• Zhu CF, Wei W, Peng X, et al. The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP. Acta Crystallogr D Biol Crystallogr. 2015;71:516–524.
   PubMedGoogle Scholar
• Li Y, Kong J, Peng X, et al. Structural insights into the high-efficiency catalytic mechanism of the sterile α-motif/histidine-aspartate domain-containing protein. J Biol Chem. 2015;290:29428–29437.
   PubMed Web of Science ®Google Scholar
• Koharudin LMI, Wu Y, DeLucia M, et al. Structural basis of allosteric activation of sterile motif and histidine-aspartate domain-containing protein 1 (SAMHD1) by nucleoside triphosphates. J Biol Chem. 2014;289:32617–32627.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bhattacharya A, Villacorta J, et al. Allosteric activation of SAMHD1 protein by deoxynucleotide triphosphate (dNTP)-dependent tetramerization requires dNTP concentrations that are similar to dNTP concentrations observed in cycling T cells. J Biol Chem. 2016;291:21407–21413.
   PubMed Web of Science ®Google Scholar
• Jang S, Zhou X, Ahn J. Substrate specificity of SAMHD1 triphosphohydrolase activity is controlled by deoxyribonucleoside triphosphates and phosphorylation at thr592. Biochemistry. 2016;55:5635–5646.
   PubMed Web of Science ®Google Scholar
• Amie SM, Daly MB, Noble E, et al. Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels. J Biol Chem. 2013;288:20683–20691.
   PubMed Web of Science ®Google Scholar
• Seamon KJ, Hansen EC, Kadina AP, et al. Small molecule inhibition of SAMHD1 dNTPase by tetramer destabilization. J Am Chem Soc. 2014;136:9822–9825.
   PubMed Web of Science ®Google Scholar
• Arnold LH, Groom HCT, Kunzelmann S, et al. Phospho-dependent regulation of SAMHD1 oligomerisation couples catalysis and restriction. PLoS Pathog. 2015;11:e1005194.
   PubMed Web of Science ®Google Scholar
• Mauney CH, Rogers LC, Harris RS, et al. The SAMHD1 dNTP triphosphohydrolase is controlled by a redox switch. Antioxid Redox Signal. 2017;27:1317–1331.
   PubMed Web of Science ®Google Scholar
• Seamon KJ, Sun Z, Shlyakhtenko LS, et al. SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity. Nucleic Acids Res. 2015;43:6486–6499.
   PubMed Web of Science ®Google Scholar
• Goncalves A, Karayel E, Rice GI, et al. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to Aicardi-Goutières syndrome-associated mutations. Hum Mutat. 2012;33:1116–1122.
   PubMed Web of Science ®Google Scholar
• White TE, Brandariz-Nuñez A, Valle-Casuso JC, et al. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology. 2013;436:81–90.
   PubMed Web of Science ®Google Scholar
• Beloglazova N, Flick R, Tchigvintsev A, et al. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutières syndrome and HIV-1 restriction. J Biol Chem. 2013;288:8101–8110.
   PubMed Web of Science ®Google Scholar
• Tüngler V, Staroske W, Kind B, et al. Single-stranded nucleic acids promote SAMHD1 complex formation. J Mol Med. 2013;91:759–770.
   PubMed Web of Science ®Google Scholar
• Seamon KJ, Bumpus NN, Stivers JT. Single-stranded nucleic acids bind to the tetramer interface of SAMHD1 and prevent formation of the catalytic homotetramer. Biochemistry. 2016;55:6087–6099.
   PubMed Web of Science ®Google Scholar
• Choi J, Ryoo J, Oh C, et al. SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology. 2015;12:46.
   PubMed Web of Science ®Google Scholar
• Ryoo J, Choi J, Oh C, et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med. 2014;20:936–941.
   PubMed Web of Science ®Google Scholar
• Ryoo J, Hwang SY, Choi J, et al. SAMHD1, the Aicardi-Goutières syndrome gene and retroviral restriction factor, is a phosphorolytic ribonuclease rather than a hydrolytic ribonuclease. Biochem Biophys Res Commun. 2016;477:977–981.
   PubMed Web of Science ®Google Scholar
• Antonucci JM, St. Gelais C, de Silva S, et al. SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity. Nat Med. 2016;22:1072–1074.
   PubMed Web of Science ®Google Scholar
• Wittmann S, Behrendt R, Eissmann K, et al. Phosphorylation of murine SAMHD1 regulates its antiretroviral activity. Retrovirology. 2015;12:103.
   PubMed Web of Science ®Google Scholar
• Daddacha W, Koyen AE, Bastien AJ, et al. SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination. Cell Rep. 2017;20:1921–1935.
   PubMed Web of Science ®Google Scholar
• Liao W, Bao Z, Cheng C, et al. Dendritic cell-derived interferon-γ-induced protein mediates tumor necrosis factor-α stimulation of human lung fibroblasts. Proteomics. 2008;8:2640–2650.
   PubMed Web of Science ®Google Scholar
• Schmidt S, Schenkova K, Adam T, et al. SAMHD1’s protein expression profile in humans. J Leukoc Biol. 2015;98:5–14.
   PubMed Web of Science ®Google Scholar
• Franzolin E, Pontarin G, Rampazzo C, et al. The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci. 2013;110:14272–14277.
   PubMed Web of Science ®Google Scholar
• Cribier A, Descours B, Valadão A, et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013;3:1036–1043.
   PubMed Web of Science ®Google Scholar
• Yan J, Hao C, DeLucia M, et al. CyclinA2-cyclin-dependent kinase regulates SAMHD1 protein phosphohydrolase domain. J Biol Chem. 2015;290:13279–13292.
   PubMed Web of Science ®Google Scholar
• St. Gelais C, de Silva S, Hach JC, et al. Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1. J Virol. 2014;88:7689–7689.
   Web of Science ®Google Scholar
• Baldauf HM, Pan X, Erikson E, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012;18:1682–1689.
   PubMed Web of Science ®Google Scholar
• St. Gelais C, de Silva S, Amie SM, et al. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology. 2012;9:105.
   PubMed Web of Science ®Google Scholar
• Diamond TL, Roshal M, Jamburuthugoda VK, et al. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem. 2004;279:51545–51553.
   PubMed Web of Science ®Google Scholar
• De Silva S, Wang F, Hake TS, et al. Downregulation of SAMHD1 expression correlates with promoter DNA methylation in sézary syndrome patients. J Invest Dermatol. 2013;134:562–565.
   PubMed Web of Science ®Google Scholar
• De Silva S, Hoy H, Hake TS, et al. Promoter methylation regulates SAMHD1 gene expression in human CD4 + T cells. J Biol Chem. 2013;288:9284–9292.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu F, Shen XY, et al. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun. 2014;455:229–233.
   PubMed Web of Science ®Google Scholar
• Welbourn S, Miyagi E, White TE, et al. Identification and characterization of naturally occurring splice variants of SAMHD1. Retrovirology. 2012;9:86.
   PubMed Web of Science ®Google Scholar
• Bloch N, Gläsker Sitaram S, Hofmann PH, et al. A highly active isoform of lentivirus restriction Factor SAMHD1 in mouse. J Biol Chem. 2016;292:1068–1080.
   PubMed Web of Science ®Google Scholar
• Pauls E, Jimenez E, Ruiz A, et al. Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1. J Immunol. 2013;190:4736–4741.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhan Y, Zhou Y, et al. Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity. Sci Rep. 2016;6:1–16.
   PubMedGoogle Scholar
• Goujon C, Schaller T, Galão RP, et al. Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection. Retrovirology. 2013;10:23.
   PubMed Web of Science ®Google Scholar
• Riess M, Fuchs NV, Idica A, et al. Interferons induce expression of SAMHD1 in monocytes through down-regulation of miR-181a and miR-30a. J Biol Chem. 2017;292:264–277.
   PubMed Web of Science ®Google Scholar
• Kyei GB, Cheng X, Ramani R, et al. Cyclin L2 is a critical HIV dependency factor in macrophages that controls samhd1 abundance. Cell Host Microbe. 2015;17:98–106.
   PubMed Web of Science ®Google Scholar
• Morrissey C, Schwefel D, Ennis-Adeniran V, et al. The eukaryotic elongation factor eEF1A1 interacts with SAMHD1. Biochem J. 2015;466:69–76.
   PubMed Web of Science ®Google Scholar
• Rocha-Perugini V, Suárez H, Álvarez S, et al. CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels. Nat Microbiol. 2017;2:1513–1522.
   PubMed Web of Science ®Google Scholar
• Welbourn S, Dutta SM, Semmes OJ, et al. Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1. J Virol. 2013;87:11516–11524.
   PubMed Web of Science ®Google Scholar
• White TE, Brandariz-Nuñez A, Valle-Casuso JC, et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe. 2013;13:441–451.
   PubMed Web of Science ®Google Scholar
• St. Gelais C, Kim SH, Ding L, et al. A putative cyclin-binding motif in human SAMHD1 contributes to protein phosphorylation, localization, and stability. J Biol Chem. 2016;291:26332–26342.
   PubMed Web of Science ®Google Scholar
• Coiras M, Bermejo M, Descours B, et al. IL-7 induces SAMHD1 phosphorylation in CD4+ T lymphocytes, improving early steps of HIV-1 life cycle. Cell Rep. 2016;14:2100–2107.
   PubMed Web of Science ®Google Scholar
• Pauls E, Ruiz A, Badia R, et al. Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol. 2014;193:1988–1997.
   PubMed Web of Science ®Google Scholar
• Pauls E, Badia R, Torres-Torronteras J, et al. Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile alpha motif and HD domain-containing protein-1 (SAMHD1) activity. AIDS. 2014;28:2213–2222.
   PubMed Web of Science ®Google Scholar
• Mlcochova P, Sutherland KA, Watters SA, et al. A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages. EMBO J. 2017;36:604–616.
   PubMed Web of Science ®Google Scholar
• Mandal M, Bandyopadhyay D, Goepfert TM, et al. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene. 1998;16:217–225.
   PubMed Web of Science ®Google Scholar
• Pauls E, Ruiz A, Riveira-Muñoz E, et al. p21 regulates the HIV-1 restriction factor SAMHD1. Proc Natl Acad Sci USA. 2014;111:E1322–E1324.
   PubMed Web of Science ®Google Scholar
• Valle-Casuso JC, Allouch A, David A, et al. p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of deoxynucleoside triphosphate biosynthesis and regulation of SAMHD1 antiviral activity. J Virol. 2017;91:e01324-17.
   PubMed Web of Science ®Google Scholar
• Mlcochova P, Caswell SJ, Taylor IA, et al. DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages. EMBO J. 2018;37:50–62.
   PubMed Web of Science ®Google Scholar
• Tang C, Ji X, Wu L, et al. Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592. J Biol Chem. 2015;290:26352–26359.
   PubMed Web of Science ®Google Scholar
• Ruiz A, Pauls E, Badia R, et al. Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages. Cell Cycle. 2015;14:1657–1665.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Wang Z, White T, et al. Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 cannot explain the retroviral restriction defect. Sci Rep. 2016;6:31353.
   PubMed Web of Science ®Google Scholar
• Poole LB. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med. 2015;80:148–157.
   PubMed Web of Science ®Google Scholar
• Go YM, Jones DP. The redox proteome. J Biol Chem. 2013;288:26512–26520.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Seo JH, Park JH, et al. SAMHD1 acetylation enhances its deoxynucleotide triphosphohydrolase activity and promotes cancer cell proliferation. Oncotarget. 2017;8:68517–68529.
   PubMedGoogle Scholar
• Bonifati S, Daly MB, St. Gelais C, et al. SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells. Virology. 2016;495:92–100.
   PubMed Web of Science ®Google Scholar
• Stillman B. Deoxynucleoside triphosphate (dNTP) synthesis and destruction regulate the replication of both cell and virus genomes. Proc Natl Acad Sci USA. 2013;110:14120–14121.
   PubMed Web of Science ®Google Scholar
• Kim B, Nguyen LA, Daddacha W, et al. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J Biol Chem. 2012;287:21570–21574.
   PubMed Web of Science ®Google Scholar
• Hollenbaugh JA, Tao S, Lenzi GM, et al. dNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages. Retrovirology. 2014;11:63.
   PubMed Web of Science ®Google Scholar
• Kretschmer S, Wolf C, Konig N, et al. SAMHD1 prevents autoimmunity by maintaining genome stability. Ann Rheum Dis. 2015;74:e17–e17.
   PubMed Web of Science ®Google Scholar
• Dragin L, Munir-Matloob S, Froehlich J, et al. Evidence that HIV-1 restriction factor SAMHD1 facilitates differentiation of myeloid THP-1 cells. Virol J. 2015;12:201.
   PubMed Web of Science ®Google Scholar
• Kodigepalli KM, Li M, Liu SL, et al. Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells. Cell Cycle. 2017;16:179–188.
   PubMed Web of Science ®Google Scholar
• Antonucci JM, St. Gelais C, Wu L. The dynamic interplay between HIV-1, SAMHD1, and the innate antiviral response. Front Immunol. 2017;8:1–9.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Swanson SK, Manel N, et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 2008;4:e1000059.
   PubMed Web of Science ®Google Scholar
• Pertel T, Reinhard C, Luban J. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology. 2011;8:49.
   PubMed Web of Science ®Google Scholar
• Amie SM, Noble E, Kim B. Intracellular nucleotide levels and the control of retroviral infections. Virology. 2013;436:247–254.
   PubMed Web of Science ®Google Scholar
• Kennedy EM, Gavegnano C, Nguyen L, et al. Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages. J Biol Chem. 2010;285:39380–39391.
   PubMed Web of Science ®Google Scholar
• Descours B, Cribier A, Chable-Bessia C, et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology. 2012;9:87.
   PubMed Web of Science ®Google Scholar
• Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474:658–661.
   PubMed Web of Science ®Google Scholar
• Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011;474:654–657.
   PubMed Web of Science ®Google Scholar
• Berger A, Sommer AFR, Zwarg J, et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 2011;7:1–12.
   Web of Science ®Google Scholar
• Sunseri N, O’Brien M, Bhardwaj N, et al. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J Virol. 2011;85:6263–6274.
   PubMed Web of Science ®Google Scholar
• Lahouassa H, Daddacha W, Hofmann H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13:223–228.
   PubMed Web of Science ®Google Scholar
• Berger G, Turpin J, Cordeil S, et al. Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. J Biol Chem. 2012;287:41210–41217.
   PubMed Web of Science ®Google Scholar
• Schwefel D, Groom HCT, Boucherit VC, et al. Structural basis of lentiviral subversion of a cellular protein degradation pathway. Nature. 2014;505:234–238.
   PubMed Web of Science ®Google Scholar
• Ahn J, Hao C, Yan J, et al. HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4 DCAF1. J Biol Chem. 2012;287:12550–12558.
   PubMed Web of Science ®Google Scholar
• Ayinde D, Bruel T, Cardinaud S, et al. SAMHD1 limits HIV-1 antigen presentation by monocyte-derived dendritic cells. J Virol. 2015;89:6994–7006.
   PubMed Web of Science ®Google Scholar
• Brégnard C, Benkirane M, Laguette N. DNA damage repair machinery and HIV escape from innate immune sensing. Front Microbiol. 2014;5:1–10.
   PubMed Web of Science ®Google Scholar
• Manel N, Hogstad B, Wang Y, et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature. 2010;467:214–217.
   PubMed Web of Science ®Google Scholar
• Maelfait J, Bridgeman A, Benlahrech A, et al. Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1. Cell Rep. 2016;16:1492–1501.
   PubMed Web of Science ®Google Scholar
• van Montfoort N, Olagnier D, Hiscott J. Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors. Cytokine Growth Factor Rev. 2014;25:657–668.
   PubMed Web of Science ®Google Scholar
• Kim ET, White TE, Brandariz-Núñez A, et al. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol. 2013;87:12949–12956.
   PubMed Web of Science ®Google Scholar
• Hollenbaugh JA, Gee P, Baker J, et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog. 2013;9:e1003481.
   PubMed Web of Science ®Google Scholar
• Behrendt R, Schumann T, Gerbaulet A, et al. Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep. 2013;4:689–696.
   PubMed Web of Science ®Google Scholar
• Sze A, Belgnaoui SM, Olagnier D, et al. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe. 2013;14:422–434.
   PubMed Web of Science ®Google Scholar
• Sommer AFR, Rivière L, Qu B, et al. Restrictive influence of SAMHD1 on Hepatitis B virus life cycle. Sci Rep. 2016;6:26616.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhu M, Pan X, et al. Inhibition of Hepatitis B virus replication by SAMHD1. Biochem Biophys Res Commun. 2014;450:1462–1468.
   PubMed Web of Science ®Google Scholar
• Gramberg T, Kahle T, Bloch N, et al. Restriction of diverse retroviruses by SAMHD1. Retrovirology. 2013;10:26.
   PubMed Web of Science ®Google Scholar
• Huber HE, Beauchamp BB, Richardson CC. Escherichia coli dGTP triphosphohydrolase is inhibited by gene 1.2 protein of bacteriophage T7. J Biol Chem. 1988;263:13549–13556.
   PubMed Web of Science ®Google Scholar
• Pfister SX, Markkanen E, Jiang Y, et al. Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation. Cancer Cell. 2015;28:557–568.
   PubMed Web of Science ®Google Scholar
• Aye Y, Li M, Long MJC, et al. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene. 2015;34:2011–2021.
   PubMed Web of Science ®Google Scholar
• Welbourn S, Strebel K. Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1. Virology. 2016;488:271–277.
   PubMed Web of Science ®Google Scholar
• Brandariz-Nuñez A, Valle-Casuso JC, White TE, et al. Contribution of oligomerization to the anti-HIV-1 properties of SAMHD1. Retrovirology. 2013;10:131.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Rehwinkel J. Aicardi-goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet. 2009;18:R130–R136.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15:429–440.
   PubMed Web of Science ®Google Scholar
• Plander M, Kalman B. Rare autoimmune disorders with Mendelian inheritance. Autoimmunity. 2016;49:285–297.
   PubMed Web of Science ®Google Scholar
• Goutières F, Aicardi J, Barth PG, et al. Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. Ann Neurol. 1998;44:900–907.
   PubMed Web of Science ®Google Scholar
• Ravenscroft JC, Suri M, Rice GI, et al. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet. 2011;155:235–237.
   Google Scholar
• Crow MK, Kirou KA, Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity. 2003;36:481–490.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Chase DS, Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet Part A. 2015;167A:296–312.
   PubMed Web of Science ®Google Scholar
• Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41:829–832.
   PubMed Web of Science ®Google Scholar
• Oda H, Nakagawa K, Abe J, et al. Aicardi-Goutières syndrome is caused by IFIH1 mutations. Am J Hum Genet. 2014;95:121–125.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Leitch A, Hayward BE, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet. 2006;38:910–916.
   PubMed Web of Science ®Google Scholar
• Rice G, Newman WG, Dean J, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;80:811–815.
   PubMed Web of Science ®Google Scholar
• Crow YJ, Hayward BE, Parmar R, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet. 2006;38:917–920.
   PubMed Web of Science ®Google Scholar
• Hu S, Li J, Xu F, et al. SAMHD1 inhibits LINE-1 retrotransposition by promoting stress granule formation. PLoS Genet. 2015;11:e1005367.
   PubMed Web of Science ®Google Scholar
• Zhao K, Du J, Han X, et al. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. Cell Rep. 2013;4:1108–1115.
   PubMed Web of Science ®Google Scholar
• Crow MK. Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease. Autoimmunity. 2010;43:7–16.
   PubMed Web of Science ®Google Scholar
• McKinnon PJ. Maintaining genome stability in the nervous system. Nat Neurosci. 2013;16:1523–1529.
   PubMed Web of Science ®Google Scholar
• Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci USA. 2011;108:5372–5377.
   PubMed Web of Science ®Google Scholar
• Ramesh V, Bernardi B, Stafa A, et al. Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol. 2010;52:725–732.
   PubMed Web of Science ®Google Scholar
• Thiele H, Du Moulin M, Barczyk K, et al. Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum Mutat. 2010;31:1836–1850.
   Web of Science ®Google Scholar
• Leshinsky-Silver E, Malinger G, Ben-Sira L, et al. A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions. Eur J Hum Genet. 2011;19:287–292.
   PubMed Web of Science ®Google Scholar
• Rehwinkel J, Maelfait J, Bridgeman A, et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J. 2013;32:2454–2462.
   PubMed Web of Science ®Google Scholar
• Kasher PR, Jenkinson EM, Briolat V, et al. Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi-Goutières syndrome. J Immunol. 2015;194:2819–2825.
   PubMed Web of Science ®Google Scholar
• Kunz BA. Mutagenesis and deoxyribonucleotide pool imbalance. Mutat Res. 1988;200:133–147.
   PubMed Web of Science ®Google Scholar
• Weinberg G, Ullman B, Martin DW. Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc Natl Acad Sci USA. 1981;78:2447–2451.
   PubMed Web of Science ®Google Scholar
• Sohl CD, Ray S, Sweasy JB. Pools and pols: mechanism of a mutator phenotype. Proc Natl Acad Sci USA. 2015;112:201505169.
   Web of Science ®Google Scholar
• Williams LN, Marjavaara L, Knowels GM, et al. dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants. Proc Natl Acad Sci USA. 2015;112:E2457–E2466.
   PubMed Web of Science ®Google Scholar
• Mertz TM, Sharma S, Chabes A, et al. Colon cancer-associated mutator DNA polymerase δ variant causes expansion of dNTP pools increasing its own infidelity. Proc Natl Acad Sci USA. 2015;112:E2467–E2476.
   PubMed Web of Science ®Google Scholar
• Bester AC, Roniger M, Oren YS, et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell. 2011;145:435–446.
   PubMed Web of Science ®Google Scholar
• Pajalunga D, Franzolin Stevanoni E, Zribi M, et al. A defective dNTP pool hinders DNA replication in cell cycle-reactivated terminally differentiated muscle cells. Cell Death Differ. 2017;24:774–784.
   PubMed Web of Science ®Google Scholar
• Rentoft M, Lindell K, Tran P, et al. Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance. Proc Natl Acad Sci USA. 2016;113:4723–4728.
   PubMed Web of Science ®Google Scholar
• Clifford R, Louis T, Robbe P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood. 2014;123:1021–1031.
   PubMed Web of Science ®Google Scholar
• Johansson P, Klein-Hitpass L, Bergmann AK, et al. SAMHD1 Is frequently involved in T-cell prolymphocytic leukemia (T-PLL) pathogenesis. Hematol Oncol. 2017;35:164–164.
   Google Scholar
• Forbes SA, Beare D, Boutselakis H, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45:D777–D783.
   PubMed Web of Science ®Google Scholar
• Kohnken R, Kodigepalli KM, Wu L. Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications. Mol Cancer. 2015;14:176.
   PubMed Web of Science ®Google Scholar
• Mathews CK. Oxidized deoxyribonucleotides, mutagenesis, and cancer. FASEB J. 2017;31:11–13.
   PubMed Web of Science ®Google Scholar
• Rudd SG, Valerie NCK, Helleday T. Pathways controlling dNTP pools to maintain genome stability. DNA Repair (Amst). 2016;44:193–204.
   PubMed Web of Science ®Google Scholar
• Parker WB. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev. 2009;109:2880–2893.
   PubMed Web of Science ®Google Scholar
• Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene. 2008;27:6522–6537.
   PubMed Web of Science ®Google Scholar
• Herold N, Rudd SG, Sanjiv K, et al. SAMHD1 protects cancer cells from various nucleoside-based antimetabolites. Cell Cycle. 2017;4101:1–10.
   Google Scholar
• Schneider C, Oellerich T, Baldauf HM, et al. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med. 2016;23:250–255.
   PubMed Web of Science ®Google Scholar
• Herold N, Rudd SG, Ljungblad L, et al. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies. Nat Med. 2017;23:256–263.
   PubMed Web of Science ®Google Scholar
• Herold N, Rudd SG, Sanjiv K, et al. With me or against me: tumor suppressor and drug resistance activities of SAMHD1. Exp Hematol. 2017;52:32–39.
   PubMed Web of Science ®Google Scholar
• Ballana E, Badia R, Terradas G, et al. SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2014;58:4804–4813.
   PubMed Web of Science ®Google Scholar
• Huber AD, Michailidis E, Schultz ML, et al. SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2014;58:4915–4919.
   PubMed Web of Science ®Google Scholar
• Arnold LH, Kunzelmann S, Webb MR, et al. A continuous enzyme-coupled assay for triphosphohydrolase activity of HIV-1 restriction factor SAMHD1. Antimicrob Agents Chemother. 2015;59:186–192.
   PubMed Web of Science ®Google Scholar
• Seamon KJ, Stivers JT. A high-throughput enzyme-coupled assay for SAMHD1 dNTPase. J Biomol Screen. 2015;20:801–809.
   PubMedGoogle Scholar